Hepatobiliary disposition of rhodamine 123 in isolated perfused rat livers

Xenobiotica

Volumn 38, Issue 10, 2008, Pages 1263-1273

  Parasrampuria, R ^a   Mehvar, R ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Hepatobiliary disposition; Isolated perfused rat liver; Multidrug resistance protein 2; P glycoprotein; Pharmacokinetics

Indexed keywords

DRUG METABOLITE; GLUCURONIDE; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 2; RHODAMINE 123;

ANIMAL TISSUE; ARTICLE; BILE; CONTROLLED STUDY; DRUG INFUSION; HEPATOBILIARY SYSTEM; LIVER PERFUSION; MALE; NONHUMAN; RAT;

ANIMALS; BILE; LIVER; MALE; METABOLIC CLEARANCE RATE; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; RHODAMINE 123; TISSUE DISTRIBUTION;

RATTUS;

EID: 53849114730     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.1080/00498250802411421     Document Type: Article

References (16)

1. Ando H, Nishio Y, Ito K, Nakao A, Wang L, Zhao YL, Kitaichi K, Takagi K, Hasegawa T. 2001. Effect of endotoxin on P-glycoprotein-mediated biliary and renal excretion of rhodamine-123 in rats. Antimicrobial Agents and Chemotherapy 45:3462-3467.
2. Annaert PP, Brouwer KL. 2005. Assessment of drug interactions in hepatobiliary transport using rhodamine 123 in sandwich-cultured rat hepatocytes. Drug Metabolism and Disposition 33:388-394.
3. Brouwer KL, Thurman RG. 1996. Isolated perfused liver. Pharmaceutical Biotechnology 8:161-192.
4. Jager W, Winter O, Halper B, Salamon A, Sartori M, Gajdzik L, Hamilton G, Theyer G, Graf J, Thalhammer T. 1997. Modulation of liver canalicular transport processes by the tyrosine-kinase inhibitor genistein: Implications of genistein metabolism in the rat. Hepatology 26:1467-1476.
5. Johnson LV, Walsh ML, Bockus BJ, Chen LB. 1981. Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy. Journal of Cellular Biology 88:526-535.
6. Johnson LV, Walsh ML, Chen LB. 1980. Localization of mitochondria in living cells with rhodamine 123. Proceedings of the National Academy of Sciences, USA 77:990-994.
7. Mehvar R, Zhang XP. 2002. Development and application of an isolated perfused rat liver model to study the stimulation and inhibition of tumor necrosis factor - a production ex vivo. Pharmaceutical Research 19:47-53.
8. National Research Council. 1996. Guide for the care and use of laboratory animals. Washington, DC: National Academy Press.
9. Naud J, Michaud J, Leblond FA, Lefrancois S, Bonnardeaux A, Pichette V. 2008. Effects of chronic renal failure on liver drug transporters. Drug Metabolism and Disposition 36:124-128.
10. Pang KS. 1984. Liver perfusion studies in drug metabolism and drug toxicity. In: Mitchell JR, Horning MG, editors. Drug metabolism and drug toxicity. New York, NY: Raven. pp 331-352.
11. Piquette-Miller M, Pak A, Kim H, Anari R, Shahzamani A. 1998. Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation. Pharmaceutical Research 15:706-711.
12. Stapf V, Thalhammer T, Huber-Huber R, Felberbauer F, Gajdzik L, Graf J. 1994. Inhibition of rhodamine 123 secretion by cyclosporin A as a model of P-glycoprotein mediated transport in liver. Anticancer Research 14:581-585.
13. Sweatman TW, Seshadri R, Israel M. 1990. Metabolism and elimination of rhodamine 123 in the rat. Cancer Chemotherapy and Pharmacology 27:205-210.
14. Turncliff RZ, Meier PJ, Brouwer KL. 2004. Effect of dexamethasone treatment on the expression and function of transport proteins in sandwich-cultured rat hepatocytes. Drug Metabolism and Disposition 32:834-839.
15. Vuppugalla R, Mehvar R. 2004. Short-term inhibitory effects of nitric oxide on cytochrome P450-mediated drug metabolism: Time dependency and reversibility profiles in isolated perfused rat livers. Drug Metabolism and Disposition 32:1446-1454.
16. Yumoto R, Murakami T, Sanemasa M, Nasu R, Nagai J, Takano M. 2001. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone. Drug Metabolism and Disposition 29:145-151.